T. Rowe Price Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

T. Rowe Price Associates’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,342,927	Closed	-$20.3M	–	2568
2020 Q1	$20.3M	Buy	5,342,927 +352,137	+7%	+$1.34M	﹤0.01%	1072
2019 Q4	$25.4M	Buy	4,990,790 +137,498	+3%	+$700K	﹤0.01%	1116
2019 Q3	$24.5M	Buy	4,853,292 +3,701,740	+321%	+$18.7M	﹤0.01%	1091
2019 Q2	$7.11M	Buy	1,151,552 +980,574	+574%	+$6.05M	﹤0.01%	1357
2019 Q1	$793K	Buy	170,978 +400	+0.2%	+$1.86K	﹤0.01%	1934
2018 Q4	$716K	Buy	170,578 +120,869	+243%	+$507K	﹤0.01%	1940
2018 Q3	$312K	Sell	49,709 -546	-1%	-$3.43K	﹤0.01%	2333
2018 Q2	$404K	Sell	50,255 -30,723	-38%	-$247K	﹤0.01%	2229
2018 Q1	$604K	Sell	80,978 -30,362	-27%	-$226K	﹤0.01%	2004
2017 Q4	$662K	Buy	111,340 +81,240	+270%	+$483K	﹤0.01%	1961
2017 Q3	$222K	Hold	30,100	–	–	﹤0.01%	2363
2017 Q2	$204K	Buy	30,100 +7,500	+33%	+$50.8K	﹤0.01%	2375
2017 Q1	$213K	Hold	22,600	–	–	﹤0.01%	2378
2016 Q4	$195K	Hold	22,600	–	–	﹤0.01%	2386
2016 Q3	$143K	Sell	22,600 -65,800	-74%	-$416K	﹤0.01%	2395
2016 Q2	$373K	Buy	88,400 +16,500	+23%	+$69.6K	﹤0.01%	2084
2016 Q1	$313K	Buy	71,900 +18,700	+35%	+$81.4K	﹤0.01%	2140
2015 Q4	$326K	Buy	53,200 +5,700	+12%	+$34.9K	﹤0.01%	2120
2015 Q3	$272K	Buy	47,500 +8,100	+21%	+$46.4K	﹤0.01%	2177
2015 Q2	$294K	Hold	39,400	–	–	﹤0.01%	2203
2015 Q1	$236K	Hold	39,400	–	–	﹤0.01%	2288
2014 Q4	$298K	Sell	39,400 -16,800	-30%	-$127K	﹤0.01%	2178
2014 Q3	$292K	Buy	56,200 +15,100	+37%	+$78.5K	﹤0.01%	2160
2014 Q2	$177K	Hold	41,100	–	–	﹤0.01%	2379
2014 Q1	$168K	Hold	41,100	–	–	﹤0.01%	2364
2013 Q4	$219K	Hold	41,100	–	–	﹤0.01%	2282
2013 Q3	$207K	Hold	41,100	–	–	﹤0.01%	2256
2013 Q2	$183K	Buy	+41,100	New	+$183K	﹤0.01%	2231